First United States 201 source cobalt-60 gamma unit for radiosurgery

Area of Science:

• Neurosurgery
• Radiation Oncology
• Medical Physics

Background:

• The introduction of advanced medical technologies often requires navigating complex regulatory landscapes.
• Stereotactic radiosurgery (SRS) offers a precise method for treating brain abnormalities.
• Cobalt-60 (60Co) gamma units have a history of use in SRS, with established protocols in other countries.

Purpose of the Study:

• To document the process and challenges associated with the introduction of the first 201-source 60Co gamma unit for SRS in the United States.
• To outline the regulatory approvals required for a new medical device utilizing radioactive sources.
• To report the commencement of clinical application and research following the installation.

Main Methods:

• Installation of a 201-source 60Co gamma unit at the University of Pittsburgh in May 1987.
• Undergoing extensive internal and governmental regulatory reviews, including those by the Health Systems Agency, Food and Drug Administration, and Nuclear Regulatory Commission.
• Initiation of clinical use and radiobiological research.

Main Results:

• The first 201-source 60Co gamma unit for SRS was successfully installed in the US.
• The introduction of this technology faced significant regulatory challenges, despite prior international experience.
• Approval for marketing and clinical use was ultimately granted following comprehensive regulatory review.

Conclusions:

• The successful installation and approval of the 60Co gamma unit mark a significant step in advancing SRS technology in the US.
• Navigating regulatory pathways is crucial for the adoption of innovative medical devices.
• Clinical implementation and ongoing research are expected to further define the role of this technology in patient care.